Endocrine Technology
2002
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
(Cancelled)
$20M
LATEST DEAL AMOUNT
Description
Owner and operator of a biotechnology company. The company focuses on filing New patent applications for the therapy of diabetes and its complications.
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 326 Livingston Street
- New York, NY 11217
- United States
+1 (718) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Endocrine Technology’s full profile, request a free trial.
Endocrine Technology Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | $20M | Cancelled | Startup | |||
| 2. Grant | 00.00 | 00.00 | Completed | Startup | ||
| 1. Angel (individual) | $2.2M | $2.2M | Completed | Startup |